Enter your login e-mail to the account
Search
Search parameters
Search results
- Osteoporosis pharmacotherapy and adherence of patient
prof. MUDr. Juraj Payer, CSc., MUDr. Kristína Brázdilová, MUDr. Peter Jackuliak, doc. MUDr. Zdenko Killinger, PhD.
(5/2010, Review articles ) - Efficiency and safety of linagliptin – relevance to clinical practice
doc. MUDr. Martin Prázný, CSc., Ph.D., MUDr. Jan Šoupal
(2/2014, Review articles ) - PAIN – AGGRAVATING SYMPTOMS
MUDr. Hedviga Jakubíková
(6/2005, Topic )
- Interactions of tobacco smoke with psychotropic medications
MUDr. Michal Turček, PhD.
(4/2011, Review articles ) - Depression in cancer patients
MUDr. Radkin Honzák, CSc.
(1/2012, Councils in psychiatry ) - Nightmares and the possibilities of their treatment
MUDr. Aleš Grambal, prof. MUDr. Ján Praško, CSc., MUDr. Daniela Jelenová, doc. MUDr. Klára Látalová, Ph.D., MUDr. Dana Kamarádová, Ph.D.
(2/2014, Digital publications )
- Breakthrough pain – clinical presentation and treatment
MUDr. Dana Vondráčková
(5/2009, Review articles ) - Léčení chronické bolesti pomocí opioidních náplasťových forem
MUDr. Dana Vondráčková
(4/2006, Review articles ) - Peripheral neuropathies in malignancies
prof. MUDr. Zdeněk Ambler, DrSc.
(5/2013, Review articles ) - Chemotherapy-induced polyneuropathy
MUDr. Jana Raputová, MUDr. Eva Vlčková, Ph.D., MUDr. Lenka Šmardová, MUDr. Aneta Rajdová, doc. MUDr. Andrea Janíková, Ph.D.
(1/2017, Main topic )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Sacituzumab govitekan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Drugs & drug classes ) - Recent achievements in targeted treatment of advanced non-small cell lung cancer with rare RET, MET, BRAF and NTRK gene alterations
MUDr. Róbert Godál
(1/2021, Main topic ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - ACCES TO INNOVATIVE DRUGS IN ONCOLOGY IN SLOVAKIA – COMPARISON WITH THE WORLD
PharmDr. Dominik Tomek, MPH
(1/2008, Review articles ) - PHARMACOECONOMICS OF ONCOLOGIC TREATMENT FORM THE POINT OF VIEW OF HEALTH INSURANCE COMPANY
MUDr. Alexander Paluch, MUDr. Lucia Vitárius, MPH
(1/2008, Review articles ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Pediatric oncology on the verge of 21. century: perspectives, aims and future visions
as. MUDr. Viera Bajčiová, CSc.
(1/2007, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - CURRENT ALTERNATIVES FOR SECOND LINE CHEMOTHERAPY OF RECURRENT CIS-PLATIN REFRACTORY EPITHELIAL OVARIAN CANCER
MUDr. Radovan Barilla
(2/2006, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - Publikujeme v zahraničí
(5/2016, Information & comments ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Originator and generics drugs and oncologic practice
prof. PharmDr. Ján Kyselovič, CSc.
(6/2013, Review articles ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2009, Information & comments ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - LHRH analogs in treatment of breast cancer
MUDr. Ján Rajec, PhD., MUDr. Lucia Dzurillová
(3/2015, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Quantification of the impact of cost-effectiveness threshold on cancer drugs reimbursement in Slovakia
RNDr. Mária Pšenková, MPH, Mgr. Marek Psota, PhD., Ing. Martin Suchanský, doc. RNDr. Martina Ondrušová, PhD., MPH
(2/2017, Main topic ) - Horizontal scanning and fast scanning system of anticancer treatment in Slovakia. The first results of the pilot project
PharmDr. Dominik Tomek, PhD., MPH1, prof. MUDr. Jozef Holomáň, CSc., MVDr. Peter Mrva, MPH
(2/2017, Main topic ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Chemotherapy for carcinoma of stomach
MUDr. Tomáš Šálek
(3/2011, Review articles ) - Publikujeme v zahraničí
(2/2017, Information & comments ) - Gastric cancer – the view of the gastroenterologist
MUDr. Boris Pekárek, PhD., MUDr. Ľuboš Žitňan, MUDr. Michal Makovník, MUDr. Juraj Májek, PhD.
(3/2011, Review articles ) - Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles ) - Poly (ADP-ribose) polymerase inhibitors in the treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(5/2017, Review articles ) - Adjuvant chemotherapy of colorectal cancer
MUDr. Vanda Ušáková, PhD., RNDr. Zdena Bartošová, CSc.
(3/2011, Review articles ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Targeted treatment of non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2022, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - Possibility of applying probiotics in oncology
prof. MUDr. Ľudovít Danihel, PhD., doc. MUDr. Michal Mego, PhD., MUDr. Vladimír Holec, MUDr. Agáta Holecová, doc. RNDr. Vladimír Zajac, CSc., Mgr. Zuzana Adamčíková
(4/2011, Review articles ) - Neurobiology of cancer: from empirism to evidences
doc. MUDr. Boris Mravec, PhD.
(5/2011, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Financial expenditures in the context of pharmacotherapy of oncological diseases
doc. PharmDr. Tomáš Tesař, PhD., MBA, PhDr. Ľubica Hlinková, MPH
(1/2014, Main topic ) - Cancer Drugs Fund – starting point or final solution to pay for innovative oncology treatment?
MUDr. Pavol Adamkov, Ing. Petra Szilágyiová, Mgr. Tomáš Pastorek
(1/2014, Main topic ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - Pharmacoeconomics and ethics in oncology: ethical dilemmas and possible solutions
Prof. MUDr. Jozef Glasa, CSc., PhD., MUDr. Helena Glasová, PhD.
(1/2014, Main topic ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - The cytoreductive surgery and HIPEC in the treatment of locally progressive malignities of abdominal cavity and carcinomatosis
MUDr. Karel Kroupa, PhD.
(5/2010, Original articles & case reports ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - News in the treatment of non-small cell lung cancer in the first half of 2023 in the world and new therapies in Slovakia
MUDr. Dominik Šafčák, PhD., MPH
(S2/2023, Review articles ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - How to treat colorectal cancer in the context of new knowledge of new molecular markers
MUDr. Tomáš Šálek, MUDr. Štefan Pörsök, PhD., MUDr. Natália Pazderová, MUDr. Zuzana Mináriková, PhD., MUDr. Eva Zomborská, MUDr. Ján Slopovský, MUDr. Benjamin Špánik
(3/2021, Review articles ) - Treatment of relapsed and refractory myeloma
MUDr. Alexander Wild
(4/2013, Focus ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - New research and therapeutic targets in molecular genetics of tumors − our research potential
RNDr. Alena Gábelová, CSc., Mgr. Miroslav Chovanec, PhD., RNDr. Ján Sedlák, DrSc., Mgr. Lucia Kučerová, PhD., RNDr. Božena Smolková, PhD., Mgr. Viera Kajabová, PhD., RNDr. Ivana Fridrichová, CSc.
(1/2015, Main topic ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Cardiotoxicity of drugs used in adjuvant therapy of breast cancer
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Katarína Ševčíková
(2/2009, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Systemic treatment of poor prognosis germ cell tumors
MUDr. Michal Mego, PhD.
(2/2009, Review articles ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - The treatment of ALK-positive NSCLC ceritinib – view panel of experts Purpose: To find out the opinion of the Panel of experts on the effectiveness and
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan
(6/2015, Information & comments ) - Be Careful What You Wish For
doc. MUDr. Peter Beržinec, CSc.
(4/2015, Information & comments ) - How are bone sarcomas seen by oncologists
MUDr. Dagmar Adámková Krákorová
(2/2011, Review articles ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - Diagnosis of pancreatobiliary tumors
doc. MUDr. Peter Makovník, CSc., MUDr. Juraj Májek, PhD.
(3/2012, Main topic ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - Systemic therapy of biliary tract cancers
MUDr. Tomáš Šálek, MUDr. Zuzana Hlavatá, MUDr. Štefan Pörsök, PhD., MUDr. Veronika Švábová, PhD.
(3/2012, Main topic ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Immune therapy of metastatic renal cell carcinoma
MUDr. Michal Chovanec, PhD.
(4/2016, Main topic ) - Publikujeme v zahraničí
(2/2013, Information & comments ) - Stroke as a consequence of vascular toxicity induced by anticancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., Mgr. Barbora Filová, MUDr. Pavol Janega, PhD.
(5/2013, Review articles ) - Complications of multiple myeloma therapy and possibilities of their influencing
MUDr. Jan Hudeček, CSc., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Ivana Plameňová, PhD.
(5/2013, Focus ) - FDA OKs bevacizumab (Avastin) for late-stage cervical cancer
doc. MUDr.Peter Beržinec, CSc.
(5/2014, Information & comments ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - ABC transporters: multidrug resistance and different types of human diseases
prof. MUDr. Stanislav Špánik, CSc., doc. MUDr. Viera Lehotská, PhD., MUDr. Katarína Rauová, RNDr. Eva Weismanová, PhD., RNDr. Ľubomír Horváth, CSc., Mgr. Ján Markus, PhD., MUDr. Ladislav Sopko
(1/2012, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - A case of a patient developed an acute coronary syndrome during the treatment with Bevacizumab
MUDr. Mária Rečková, Prof. MUDr. Beata Mladosievičová, CSc., MUDr. Barbora Piteková
(5/2015, Original articles & case reports ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(6/2010, Review articles ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - Adjuvant therapy in malignant melanoma
MUDr. Zuzana Hlavatá
(6/2010, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Changes of bone mineral density in patients with testicular cancer
doc. MUDr. Jozef Mardiak, CSc., prof. MUDr. Juraj Payer, CSc., MUDr. Beata Špániková
(6/2012, Main topic ) - Pembrolizumab for the treatment of non-small-cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(2/2015, Information & comments ) - Personalization of treatment of colorectal cancer in 1st line
MUDr. Štefan Pörsök, PhD., MUDr. Natália Pazderová, MUDr. Ján Slopovský, MUDr. Tomáš Šálek
(4/2020, Main topic ) - Nonopioid analgesics and adjuvants in treatment of cancer pain
MUDr. Miroslav Ferenčík
(1/2017, Main topic ) - The role of biomarkers in cardiotoxicity detection in childhood cancer survivors
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Dagmar Urbanová
(4/2010, Original articles & case reports ) - Optimal first-line treatment of mCRC
MUDr. Jana Ďurková
(1/2017, Review articles ) - Psychotherapy and psychopharmacotherapy in oncology
Mgr. Lucia Vasiľková, MUDr. Katarína Tisovská
(1/2017, Review articles ) - Alternative and complementary medicine in cancer patient
MUDr. Mária Rečková
(5/2009, Review articles ) - Treatment of patient with metastatic prostate cancer – from sensitive to castration resistant disease – case report
MUDr. Vladimír Lenko, PhD., FEBU
(S1/2020, Case reports ) - Initial treatment of metastatic renal cell carcinoma
MUDr. Jana Obertová, PhD.
(1/2018, Main topic ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - ADVANCES IN NEUROBLASTOMA DIAGNOSTICS AND TREATMENT
MUDr. Viera Bajčiová, CSc., MUDr. Pavel Mazánek, prof. MUDr. Jaroslav Šterba, PhD.,, doc. RNDr. Petr Kuglík, CSc., doc. RNDr. Renata Veselská, PhD.
(4/2008, Review articles ) - Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Information & comments ) - CONTEMPORARY POSSIBILITY OF THE TREATMENT OF BONE METASTASES
prof. MUDr. Ľudovít Jurga, CSc.
(3/2007, Review articles - treatment ) - Molecular classification of liposarcomas
RNDr. Katarína Hlinková
(6/2011, Review articles )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Current view on skin photoprotection
doc. MUDr. Karel Ettler, CSc., MUDr. Jiří Ettler
(3/2016, Review articles ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - Treatment of cancer pain in dermatology
MUDr. Miroslav Ferenčík, Mgr. Ľuboš Mazúr, MPH
(2/2020, Interdisciplinary consilium )
- LÉČENÍ CHRONICKÉ BOLESTI POMOCÍ OPIOIDNÍCH NÁPLASŤOVÝCH FOREM
MUDr. Dana Vondráčková
(3-4/2007, clearly ) - PHARMACOTHERAPY OF BENIGN PROSTATIC HYPERPLASIA, PREVENTION, EFFECTIVE MEDICATIONS, ADVERSE EVENTS
MUDr. Miloš Broďák, MUDr. Lukáš Holub
(2/2007, clearly ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly )
- Biological drugs from the perspective of pharmacy
PharmDr. Katarína Bruchatá, PhD., Mgr. Peter Heinz
(4/2014, Pharmaceutical technology ) - Natural products for treating symptoms of influenza and flu
Doc. RNDr. Daniela Košťálová, CSc.
(3-4/2015, Phytotherapy ) - Multifarious world of antifungal agents
prof. RNDr. Dušan Mlynarčík, DrSc.
(1/2013, Current pharmacotherapy ) - Ibuprofen from the point of view of contemporary pharmacist
PharmDr. Tatiana Geročová, PhD.
(2/2012, Current pharmacotherapy )
- Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(3/2011, Review articles ) - A fixed combination Cyclo 3 Fort in the treatment of CVI
MUDr. Jiří Slíva, Ph.D.
(2/2016, Drugs & drug classes )